The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

Oncogene

Volumn 15, Issue 5, 1997, Pages 537-547

  Pegram, Mark D ^a   Finn, Richard S ^a   Arzoo, Karo ^a   Beryt, Malgorzata ^a   Pietras, Richard J ^a   Slamon, Dennis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Chemotherapy; Drug resistance; HER 2 neu (c erbB 2); Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COMPLEMENTARY DNA; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; TAMOXIFEN; THIOTEPA; VINBLASTINE;

ANIMAL MODEL; ARTICLE; BREAST CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DNA TRANSFECTION; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ONCOGENE NEU; OVARY CANCER; PRIORITY JOURNAL; XENOGRAFT;

ANIMALIA;

EID: 0030870295     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201222     Document Type: Article

References (73)

1. Aboud-Pirak E, Hurwitz E, Pirak ME, Bellot F, Schlessinger J and Sela M. (1988). J. Natl. Cancer Inst., 80, 1605-1611.
2. Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff M, Eudey L and McGuire WL. (1992). J. Clin. Oncol., 10, 599-605.
3. Anbazhagan R, Gelber RD, Bettelheim R, Goldhirsch A and Gusterson BA. (1991). Ann. Oncol., 2, 47-53.
4. Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD and Stewart SJ. (1994). Cancer Res., 54, 3758-3765.
5. Barbareschi M, Leonardi E, Mauri FA, Serio G and Palma PD. (1992). Am. J. Clin. Pathol., 98, 408-418.
6. Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM and Osborne CK. (1992). Breast Cancer Res. and Treat., 24, 85-95.
7. Berchuck A, Rodriguez G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL and Bast Jr, RC. (1991). Am. J. Obstet. Gynecol., 164, 15-21.
8. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B and Hynes NE. (1988). Cancer Res., 48, 1238-1242.
9. Berns EMJJ, Foekens JA, van Staveren IL, van Putten WLJ, de Koning HYWCM, Portengen H and Klijn JGM. (1995). Gene, 159, 11-18.
10. Borg A, Baldetorp M, Ferno M, Killander D, Olsson H and Sigurdsson H. (1991). Oncogene, 6, 137-143.
11. Burt RK, Garfield S, Johnson K and Thorgeirsson SS. (1988). Carcinogenesis, 9, 2329-2332.
12. Casciari JJ, Holingshead MG, Alley MC, Mayo JG, Malspeis L, Miyauchi S, Grever MR and Weinstein JN. (1994). J. Natl. Cancer Inst., 86, 1846-1852.
13. Chazin VR, Kaleko M, Miller AD and Slamon DJ. (1992). Oncogene, 7, 1859-1866.
14. Christen RD, Hom DK, Porter DC, Andrews PA, MacLeod CL, Hafstrom L and Howell SB. (1990). J. Clin. Invest., 86, 1632-1640.
15. Cohen BE, Egorin MJ, Kohlhepp EA, Aisner J and Gutierrez PL. (1986). Cancer Treat. Rep., 70, 859-864.
16. Dickstein B, Valerius EM, Wosikowski K, Saceda M, Pearson JW, Martin MB and Bates SE. (1993). J. Cell Physiol., 157, 110-118.
17. Dickstein BM, Wosikowski K and Bates S. (1995). Molec. and Cell Endocrinol., 110, 205-211.
18. D'Incalci M, Farina P, Sessa C, Mangioni C, Conter V, Masera G, Rocchetti M, Brambilla Pisoni M, Piazza E, Beer M and Cavalli F. (1982). Cancer Chemother. Pharmacol., 7, 141-145.
19. DiSaia PJ, Sinkovics J, Rutlege FN and Smith JP. (1972). Am. J. Obstet. Gynecol., 114, 979-989.
20. Endicott JA and Ling V. (1989). Ann. Rev. Biochem., 58, 137-171.
21. Felip E, Del Campo JM, Rubio D, Vidal MT, Colomer R and Bermejo B. (1995). Cancer, 75, 2147-2152.
22. Flick DA and Gifford GE. (1984). J. Immunological Methods, 68, 167-175.
23. Gillies RJ, Didier N and Denton M. (1986). Anal. Biochem., 159, 109-113.
24. Gormley PE, Bull JM, LeRoy AF and Cysyk R. (1979). Clin. Pharmacol. Ther., 25, 351-357.
25. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R, Styles J, Rudenstam C-M, Golouh R, Reed R, Martinez-Tello F, Tiltman A, Torhorst J, Grigolato P, Bettelheim R, Neville AM, Burke K, Castiglione M, Collins J, Lindtner J and Senn H-J. (1992). J. Clin. Onc., 10, 1049-1056.
26. Hancock MC, Langton BC, Chan T, Toy P, Monahan JJ, Mischak RP and Shawver LK. (1991). Cancer Res., 51, 4575-4580.
27. Harland SJ, Newell DR, Siddik ZH, Chadwick R, Hilary Calvert A and Harrup KR. (1984). Cancer Res., 44, 1693-1697.
28. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS and Podratz KC. (1992). Gynecologic Oncol., 47, 179-185.
29. Isonishi S, Hom DK, Thiebaut FB, Mann SC, Andrews PA, Basu A, Lazo J, Eastman A and Howell SB. (1991). Cancer Res., 51, 5903-5909.
30. Kallioniema OP, Holli K, Visakorpi T, Koivula T, Helin HH and Isola JJ. (1991). Int. J. Cancer, 49, 650-655.
31. Kerbel RS. (1995). Invasion and Metastasis, 14, 50-60.
32. Kerbel RS, Rak J, Kobayashi H, Man MS, St Croix B and Graham CH. (1994). Cold Spring Harbor Symposia on Quantitative Biology, 59, 661-672.
33. Klijn JGM, Berns EMJJ and Foekens JA. (1993). Cancer Surveys Volume 18: Breast Cancer. Sidebottom E. (ed.). Cold Spring Harbor Laboratory Press: New York, pp. 165-198.
34. Kobayashi H, Man S, Graham CH, Kapitain SJ, Teicher BA and Kerbel RS. (1993). Proc. Natl. Acad. Sci. USA, 90, 3294-3298.
35. Lee AKC, Wiley B, Loda M, Dugan JM, Hamilton W, Heatley GJ, Cook L and Silverman ML. (1992). Mod. Pathol., 5, 61-67.
36. Liu LF. (1989). Annu. Rev. Biochem., 58, 351-375.
37. Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearxon DL, Bast Jr, RC and Berchuck A. (1994). Cancer, 73, 2380-2385.
38. MacMillan WE, Wolberg WH and Welling PG. (1978). Cancer Res., 38, 3479-3482.
39. Meyers MB, Merluzzi VJ, Spengler BA and Biedler JL. (1986). Proc. Natl. Acad. Sci. USA, 83, 5521-5525.
40. Meyers MB, Yu P and Mendelsohn J. (1993). Biochem. Pharmacol., 46, 1841-1848.
41. Muss HB, Thor A, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M and Henderson IC. (1994). N. Engl. J. Med., 330, 1260-1266.
42. Nelson RL, Dyke RW and Root MA. (1980). Cancer Treat. Rev., 7 (suppl.), 17-24.
43. Niimi S, Nakagawa K, Yokata J, Tsuuokawa Y, Nishio K, Terashima Y, Shibuya M, Terada M and Saijo N. (1991). Br. J. Cancer, 63, 237-241.
44. Nuti M, Zupi G, D'agnano I, Turchi V, Candiloro A and Frati L. (1991). Anticancer Res., 11, 1225-1230.
45. Pantel K, Schlimok Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR and Riethmuller G. (1993). J. Natl. Cancer Inst., 85, 1419-1423.
46. Pauletti G, Godolphin W, Press MF and Slamon DJ. (1996). Oncogene, 13, 63-72.
47. Peters GJ, Wets M, Keepers YPAM, Oskam R, Ark-Otte JV, Noordhuis P, Smid K and Pinedo HM. (1993). Int. J. Cancer, 54, 450-455.
48. Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB and Slamon DJ. (1994). Oncogene, 9, 1829-1838.
49. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX and Slamon DJ. (1995). Oncogene, 10, 2435-2446.
50. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM and Buckley S. (1993). Nature, 366, 473-475.
51. Poller DN, Galea M, Pearson D, Bell J, Gullick WJ, Elston CW, Blarney RW and Ellis IO. (1991). Breast Cancer Res. and Treat., 20, 3-10.
52. Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG and El-Naggar AK. (1994). Cancer Res., 54, 5675-5682.
53. Quenel N, Wafflart J, Bonichon F, de Mascarel I, Trojani M, Durand M, Avril A and Coindre JM. (1995). Breast Cancer Res. and Treat., 35, 283-291.
54. Querzoli P, Marchetti E, Fabris G, Marzola A, Ferretti S, Iacobelli S, Hazan R, King CR and Nenci I. (1990). Tumori, 76, 461-464.
55. Rajkumar T and Gullick W. (1994). Breast Cancer Res. and Treat., 29, 3-9.
56. Reile H, Birnbock H, Bernhardt G, Sprub T and Schonenberger H. (1990). Anal. Biochem., 187, 262-267.
57. Robert J, Illiadis A, Hoerni B, Cano J-P, Durand M and Lagarde C. (1982). Eur. J. Cancer Clin. Oncol., 18, 739-745.
58. Sabbatini ARM, Basolo F, Valentini P, Mattii L, Calvo S, Fiore L, Ciardiello F and Petrini M. (1994). Int. J. Cancer. 59, 208-211.
59. Saffari B, Jones LA, el-Naggar A, Felix JC, George J and Press MF. (1995). Cancer Res., 55, 5693-5698.
60. Scanlon KJ, Kashani-Sabet M, Miyachi H, Sowers LC and Rossi J. (1989). Anticancer Res., 9, 1301-1312.
61. Semba K, Kamata N, Toyoshima K and Yamamoto T. (1985). Proc. Natl. Acad. Sci. USA, 82, 6497-6501.
62. Seshadri R, Firgaira FA, Horsfall DJ, McCaul K, Setlur V and Kitchen P. (1993). J. Clin. Oncol., 11, 1936-1942.
63. Sklar MD and Prochownik EV. (1991). Cancer Res., 51, 2118-2123.
64. Slamon DJ, Clark GM, Wong SJ, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
65. Sliwkowski MX, Schaefer G, Akita RW, Lofren JA, Fitzpatrick VD, Nuijens A, Fendley BM, Cerione RA, Vandlen RL and Carraway III K. (1994). J. Biol. Chem., 269, 14661-14665.
66. Smith K, Houlbrook S, Greenall M, Carmichael J and Harris AL. (1993). Oncogene, 8, 933-938.
67. Stal O, Sullivan S, Sun XF, Wingren S and Nordenskjold B, (1994). Cytometry, 16, 160-168.
68. Tsai C-M, Chang K-T, Perng R-P, Mitsudomi T, Chen M-H, Kadoyama C and Gazdar AF. (1993). J. Natl. Cancer Inst., 85, 897-901.
69. Tsai C-M, Yu D, Chang K-T, Wu L-H, Perng R-P, Ibrahim NK and Hung M-C. (1995). J. Natl. Cancer Inst., 87, 682-684.
70. Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB and Paietta E. (1987). Cancer Res., 47, 2486-2493.
71. Wright C, Cairns J, Cantwell BJ, Cattan AR, Hall AG, Harris AL and Home CHW. (1992). Br. J. Cancer. 65, 271-274.
72. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M and Sasaki T. (1991). Cancer Res., 51, 1034-1038.
73. Yu D, Liu B, Tan M, Li J, Wang S-S and Hung M-C. (1996). Oncogene, 13, 1359-1365.